Published in J Infect Dis on November 15, 2007
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog (2009) 2.29
Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies. Clin Vaccine Immunol (2010) 1.59
Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One (2012) 1.54
A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol (2011) 1.53
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLoS Negl Trop Dis (2012) 1.51
Filovirus tropism: cellular molecules for viral entry. Front Microbiol (2012) 1.18
Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis (2011) 1.14
Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus. PLoS One (2014) 1.08
Antibody-dependent enhancement of Marburg virus infection. J Infect Dis (2011) 1.02
Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts. J Virol (2012) 1.02
Potential vaccines and post-exposure treatments for filovirus infections. Viruses (2012) 0.94
Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus. Infect Dis Poverty (2014) 0.94
Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus. J Virol (2013) 0.92
Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy. J Venom Anim Toxins Incl Trop Dis (2015) 0.87
In silico analysis suggests interaction between Ebola virus and the extracellular matrix. Front Microbiol (2015) 0.86
Ebolavirus comparative genomics. FEMS Microbiol Rev (2015) 0.82
Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain. Virol J (2012) 0.81
Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. PLoS One (2013) 0.81
Contribution of Sec61α to the life cycle of Ebola virus. J Infect Dis (2011) 0.81
sGP serves as a structural protein in Ebola virus infection. J Infect Dis (2011) 0.80
Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells. Plant Cell Rep (2016) 0.78
Fcγ-receptor IIa-mediated Src Signaling Pathway is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection. PLoS Pathog (2016) 0.75
A Perspective on the Development of Plant-Made Vaccines in the Fight against Ebola Virus. Front Immunol (2017) 0.75
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Ebola haemorrhagic fever. Lancet (2011) 8.28
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature (2003) 6.35
Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature (2004) 6.11
PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology (2004) 5.96
Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol (2005) 5.28
Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J Virol (2006) 5.26
Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature (2006) 4.52
Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog (2007) 4.49
Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses. J Virol (2009) 4.20
Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature (2008) 4.18
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77
Characterization of H7N9 influenza A viruses isolated from humans. Nature (2013) 3.71
Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69
Gain-of-function experiments on H7N9. Science (2013) 3.67
Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol (2002) 3.62
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis (2007) 3.47
Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A (2003) 3.45
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell (2013) 3.19
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA (2007) 3.00
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99
The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol (2005) 2.89
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A (2003) 2.82
A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol (2007) 2.80
Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology (2005) 2.77
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Clin Infect Dis (2006) 2.72
Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71
Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol (2006) 2.70
Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol (2003) 2.67
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog (2007) 2.64
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS Med (2006) 2.64
Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog (2009) 2.62
Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol (2006) 2.60
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. J Virol (2002) 2.58
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol (2008) 2.58
Human infection with highly pathogenic H5N1 influenza virus. Lancet (2008) 2.57
Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol (2005) 2.55
Pneumonia from human coronavirus in a macaque model. N Engl J Med (2013) 2.47
Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol (2005) 2.45
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog (2009) 2.44
Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis (2007) 2.44
Molecular determinants of Ebola virus virulence in mice. PLoS Pathog (2006) 2.44
Selection of H5N1 influenza virus PB2 during replication in humans. J Virol (2009) 2.42
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. J Virol (2009) 2.41
Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol (2004) 2.34
An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci U S A (2005) 2.33
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33
Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A (2013) 2.29
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol (2005) 2.27
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Pause on avian flu transmission research. Science (2012) 2.24
Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24
Cellular networks involved in the influenza virus life cycle. Cell Host Microbe (2010) 2.23
Nedd4 regulates egress of Ebola virus-like particles from host cells. J Virol (2003) 2.19
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog (2008) 2.10
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
The ecology of Ebola virus. Trends Microbiol (2007) 2.08
Disease modeling for Ebola and Marburg viruses. Dis Model Mech (2009) 2.07
The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly. J Virol (2006) 2.07
Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett (2002) 2.06
An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A (2009) 2.04